NEPHROSANT
NephroSant is a fast-paced diagnostic startup founded by physicians, with a team of world-class scientists, engineers and clinicians, focused on applying the founding team's years of clinical research expertise to improve global kidney health.
NEPHROSANT
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2017-01-01
Address:
Brisbane, California, United States
Country:
United States
Website Url:
http://www.nephrosant.com
Total Employee:
11+
Status:
Active
Contact:
+1 833 697 7268
Total Funding:
16 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Employees Featured
Founder
Investors List
DaVita Venture Group
DaVita Venture Group investment in Series A - Nephrosant
DigitalDx Ventures
DigitalDx Ventures investment in Series A - Nephrosant
Official Site Inspections
http://www.nephrosant.com Semrush global rank: 5.6 M Semrush visits lastest month: 1.51 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Nephrosant"
NephroSant, Inc. - LinkedIn
NephroSant, Inc. | 2,058 followers on LinkedIn. Kidney Health Redefined | Kidney transplantation is the treatment of choice for patients with end-stage kidney failure.See details»
Nephrosant - Crunchbase Company Profile & Funding
NephroSant is a fast-paced diagnostic startup founded by physicians, with a team of world-class scientists, engineers and clinicians, focused on applying the founding team's years of clinical …See details»
Nephrosant Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Nephrosant. Use the PitchBook Platform to explore the full profile.See details»
NephroSant - Overview, News & Similar companies
NephroSant contact info: Phone number: (415) 825-5598 Website: www.nephrosant.com What does NephroSant do? Based in Brisbane, California, NephroSant is a fast-paced diagnostic …See details»
Nephrosant - Contacts, Employees, Board Members, …
NephroSant’s mission is to deliver new diagnostic tools for early detection and lifetime monitoring of kidney health and injury.See details»
NephroSant Launches Two-Year Study of 2,000 Kidney …
Mar 21, 2022 · Eligible participants will have undergone kidney transplant within 90 days of enrollment. Up to 2,000 individuals are being enrolled and followed for 24 months, during …See details»
NephroSant Announces $16 Million Series A, …
Mar 16, 2021 · SAN FRANCISCO, CA / ACCESSWIRE / March 16, 2021 / NephroSant, a kidney health spin out of UC San Francisco, today announced it has closed its oversubscribed Series A funding round of $16 million.See details»
Joshua Yang - Co-Founder and CEO - Crunchbase
Hi, I'm Josh, the co-founder and CEO of Glyphic Biotechnologies, a VC-funded biotechnology startup commercializing a next-generation protein sequencing platform. My first startup …See details»
NephroSant Announces Mark Capone as Independent …
Feb 16, 2021 · NephroSant, a Kidney Health spin out of UCSF, today announced that Mark Capone has officially joined the Board of Directors. Following the appointment of Mr. Capone, …See details»
NephroSant Launches Two-Year Study of 2,000 …
NephroSant, Inc. a biotechnology company dedicated to accelerating the assessment of early kidney damage with a mission to significantly improve global kidney health, announced the first patient has been enrolled into the …See details»
NephroSant Launches Two-Year Study of 2,000 Kidney
Mar 21, 2022 · NephroSantâ„¢, Inc. a biotechnology company dedicated to accelerating the assessment of early kidney damage with a mission to significantly improve global kidney …See details»
NephroSant hires new lead to market home-based kidney …
Aug 9, 2021 · NephroSant, a startup operating out of the University of California, San Francisco that developed a test to detect graft rejection following kidney transplantation, has hired Gina …See details»
NephroSant Announces $16 Million Series A, Led by …
SAN FRANCISCO, March 16, 2021 (Newswire.com) - NephroSant, a kidney health spin out of UC San Francisco, today announced it has closed its oversubscribed Series A funding round of …See details»
NephroSant Executives Recognized for Contributions to …
SAN FRANCISCO, Aug. 16, 2021 /PRNewswire/ -- NephroSant, a kidney health spin out of UCSF, today announced that it has recently been recognized by renowned industry …See details»
NephroSant Secures Medicare Coverage for QSant, the …
Sep 22, 2021 · QSant is the first available product to deliver accurate identification of kidney transplant rejection risk from a non-timed urine sample that can be collected in the comfort of a …See details»
NephroSant Launches Two-Year Study of 2,000 Kidney …
Mar 21, 2022 · Eligible participants will have undergone kidney transplant within 90 days of enrollment. Up to 2,000 individuals are being enrolled and followed for 24 months, during …See details»
NephroSant Features QSant, the first urine test for kidney …
Jan 3, 2022 · Nephrosant â„¢ is dedicated to improving global kidney health through a growing pipeline of products including QSant â„¢, the company's flagship diagnostic test. To learn more, …See details»
QiSant™ Initial Publication Demonstrates Strong Clinical …
SAN FRANCISCO, March 18, 2020 /PRNewswire/ -- NephroSant, a startup company that is focused on redefining kidney health, today announced the landmark publication showing high …See details»
NephroSant Publishes Real-World Evidence Showing …
SAN FRANCISCO, March 3, 2022 /PRNewswire/ -- NephroSantâ„¢ a biotechnology company dedicated to accelerating the diagnosis of early kidney damage in native and transplanted …See details»